1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

HTScience

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2019

Location

Guangzhou Guangdong China

Primary Industry

Biotechnology

About

Established in 2019 and based in Guangzhou, China, HTScience is a pre-clinical and life science research and development outsourcing service provider, headquartered in Guangzhou and has subsidiaries in Foshan and Shenzhen, with a laboratory area of over 10,000 square meters, also has a core team of scientists from universities and research and development institutions such as South China University of Technology and National University of Singapore. At the same time, the company has provided technical services for Baiyunshan Pharmaceutical, Microchip Bio and other institutions and manufacturers, and has successfully submitted several IND applications to USFDA and CFDA, and entered clinical trials. In September 2024, it closed a venture funding from Jinkong Fund Management. The company specializes in preclinical research and development outsourcing services for pharmaceuticals, medical devices, gene and cell therapies. It uses technologies such as gene editing, surgical modeling and chemical diet induction to construct animal models of human diseases, which can simulate the development of clinical diseases and provide a tool platform for biopharmaceutical research and development. HTScience generates revenue by providing R&D outsourcing services such as high-throughput disease target screening, gene-edited cell line construction, disease animal model construction, pharmacology, drug metabolism and safety evaluation (Non-GLP).
Current Investors
Guangzhou Zhongke Yuechuang Incubator Investment, Wanlian Tianze, Yanghe Biomedicine Industry Investment

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Outsourcing, Biotechnology, Healthcare Specialists
Website
www.htscience.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.